Charles Sweeney (CEO), Kirsten Lord, (Chief Clinical Officier and Founder), David Ovens (Joint Managing Director of Archangel Investors)
Scottish health tech PhysioMedics secures £1.5M to expand into Europe and India
PhysioMedics is poised to scale its commercial operations after securing growth capital from
investors led by Archangels, the world’s longest continually operated business angel syndicate. The
investment follows the appointment last year of experienced CEO, Charles Sweeney, to lead the
company through the next stage of its growth.
Edinburgh-based PhysioMedics secured equity and grant funding totalling £1.5m from Archangels,
Scottish Enterprise and Innovate UK to allow it to accelerate its commercial growth and product
roadmap, including expanding into European and Indian markets.
The company’s PhysioWizard platform is the only clinically validated self-assessment tool for muscle
and joint problems that patients can complete online, without requiring a clinician. PhysioWizard
accurately matches patients with the recommended treatment (triage), and the platform provides
patient-led self-care and advice, enabling users to actively participate in their treatment and achieve
better results. With 6 in 10 home workers reporting muscle and joint issues, the demand for quick
instant access to care has increased significantly with COVID, driven by the move to hybrid working.
Charles Sweeney has more than 20 years’ experience of leading companies in a range of sectors. He
has a long association with Archangels, who continue to support PhysioMedics. Charles is currently
non-executive chairman of another Archangels portfolio company, Hearing Diagnostics, and a board
member of the Glasgow-based Digital Health and Care Innovation Centre.
PhysioMedics was founded by Kirsten Lord in 2010, a Chartered Physiotherapist with over 30 years’
experience of treating thousands of patients, working with a team of specialist physiotherapists.
Charles Sweeney said: “The further investment secured from Archangels and Scottish Enterprise
comes at an important stage of our journey, as we move from product development and early
commercialisation, into a more focused phase of commercial growth. The Innovate UK grant will also
allow us to accelerate the pace of our product roadmap which will revolutionise how musculoskeletal
triage is delivered to customers.”
David Ovens, Joint MD of Archangels, said: “In a post-pandemic world, web-based clinical triage is
becoming an increasingly an important part of how healthcare is delivered in the UK and globally,
providing a vital service and reducing the burden on healthcare teams. I have no doubt that the
clinical depth of the PhysioWizard product, which has been developed over many years, will ensure
that it becomes the leading digital triage solution not only in the UK but globally.”
Kerry Sharp, Director of Entrepreneurship and Investment at Scottish Enterprise, said: “Since the
pandemic, more and more people are turning to digital healthcare solutions and PhysioMedics is
helping to meet that market demand with its PhysioWizard product. We’ve supported the company
in various ways since its early days and are pleased to see it continue to scale up and expand
internationally.”
For further information on PhysioMedics and the PhysioWizard platform, please visit:
https://www.physiomedics.com/
Featured in The Scotsman, DIGIT, Daily Business, Tech Funding News, Archangel Investment Limited, Scottish Financial News, UKTN
PhysioMedics is poised to scale its commercial operations after securing growth capital from
investors led by Archangels, the world’s longest continually operated business angel syndicate. The
investment follows the appointment last year of experienced CEO, Charles Sweeney, to lead the
company through the next stage of its growth.
Edinburgh-based PhysioMedics secured equity and grant funding totalling £1.5m from Archangels,
Scottish Enterprise and Innovate UK to allow it to accelerate its commercial growth and product
roadmap, including expanding into European and Indian markets.
The company’s PhysioWizard platform is the only clinically validated self-assessment tool for muscle
and joint problems that patients can complete online, without requiring a clinician. PhysioWizard
accurately matches patients with the recommended treatment (triage), and the platform provides
patient-led self-care and advice, enabling users to actively participate in their treatment and achieve
better results. With 6 in 10 home workers reporting muscle and joint issues, the demand for quick
instant access to care has increased significantly with COVID, driven by the move to hybrid working.
Charles Sweeney has more than 20 years’ experience of leading companies in a range of sectors. He
has a long association with Archangels, who continue to support PhysioMedics. Charles is currently
non-executive chairman of another Archangels portfolio company, Hearing Diagnostics, and a board
member of the Glasgow-based Digital Health and Care Innovation Centre.
PhysioMedics was founded by Kirsten Lord in 2010, a Chartered Physiotherapist with over 30 years’
experience of treating thousands of patients, working with a team of specialist physiotherapists.
Charles Sweeney said: “The further investment secured from Archangels and Scottish Enterprise
comes at an important stage of our journey, as we move from product development and early
commercialisation, into a more focused phase of commercial growth. The Innovate UK grant will also
allow us to accelerate the pace of our product roadmap which will revolutionise how musculoskeletal
triage is delivered to customers.”
David Ovens, Joint MD of Archangels, said: “In a post-pandemic world, web-based clinical triage is
becoming an increasingly an important part of how healthcare is delivered in the UK and globally,
providing a vital service and reducing the burden on healthcare teams. I have no doubt that the
clinical depth of the PhysioWizard product, which has been developed over many years, will ensure
that it becomes the leading digital triage solution not only in the UK but globally.”
Kerry Sharp, Director of Entrepreneurship and Investment at Scottish Enterprise, said: “Since the
pandemic, more and more people are turning to digital healthcare solutions and PhysioMedics is
helping to meet that market demand with its PhysioWizard product. We’ve supported the company
in various ways since its early days and are pleased to see it continue to scale up and expand
internationally.”
For further information on PhysioMedics and the PhysioWizard platform, please visit:
https://www.physiomedics.com/
Featured in The Scotsman, DIGIT, Daily Business, Tech Funding News, Archangel Investment Limited, Scottish Financial News, UKTN
PhysioMedics™ is a digital healthcare innovation leader, providing software-as-a-service & data analytic insights to reduce costs and improve efficiencies in managing musculoskeletal (MSK) conditions.
|
Qualifying as a physiotherapist in Adelaide, Australia in 1989, Kirsten moved to Scotland in 1991 and founded The Physio Centres (Edinburgh & Glasgow) in 1992, which she grew to become one of the biggest privately owned physiotherapy groups in Scotland providing in excess of 15,000 treatments per annum.
In 2010, Kirsten founded PhysioMedics™ a technology company that aims to improve the experience of those with muscle and joint conditions. Physiotherapists have the rare opportunity to make a significant impact on people’s lives and Kirsten recognised the potential of software to deliver personalised care at scale, for the wellbeing of numerous people.
Kirsten continues to lead the innovation and clinical development of the PhysioWizard® platform, an intuitive software-as-a-service (SaaS) MSK triage system that patients complete online to receive guidance, early advice and information. PhysioWizard® is a decision support tool that truly empowers patients. The platform improves operational efficiencies and reduces costs in organisations managing MSK conditions (Occupational Health, Health Insurance, physio network providers, private practices, NHS and Corporate Health & Wellness).
In short, Kirsten has built PhysioMedics™ on a foundation of the ethical care of people, changing the way patients want healthcare delivered and raising the bar on clinical care.
In 2010, Kirsten founded PhysioMedics™ a technology company that aims to improve the experience of those with muscle and joint conditions. Physiotherapists have the rare opportunity to make a significant impact on people’s lives and Kirsten recognised the potential of software to deliver personalised care at scale, for the wellbeing of numerous people.
Kirsten continues to lead the innovation and clinical development of the PhysioWizard® platform, an intuitive software-as-a-service (SaaS) MSK triage system that patients complete online to receive guidance, early advice and information. PhysioWizard® is a decision support tool that truly empowers patients. The platform improves operational efficiencies and reduces costs in organisations managing MSK conditions (Occupational Health, Health Insurance, physio network providers, private practices, NHS and Corporate Health & Wellness).
In short, Kirsten has built PhysioMedics™ on a foundation of the ethical care of people, changing the way patients want healthcare delivered and raising the bar on clinical care.
